Estimados associados e simpatizantes do melhor clube do mundo, os meus cumprimentos, o ano de 2024 ficou marcado por uma série infindável de memórias e histórias alicerçadas em alegrias e tristezas ma ...
Seja no primeiro ou no último dia do ano, sempre há algumas tarefas a serem feitas. Neste ano, a véspera de Ano Novo cai em ...
A sign with the company logo stands in front of the Eli Lilly and Company headquarters campus in Indianapolis, Indiana, on March 17, 2024. New study data has solidified the club's position Eli Lillyis ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
Matheus Araújo foi anunciado como novo reforço do Ceará, que disputará a Série A em 2025. Revelado pelo Corinthians, o meio-campista assinou contrato por três temporadas com a equipe nordestina. Ele ...
Ozempic maker Novo Nordisk saw its value fall by as much as £82billion yesterday after a weight loss drug trial fell short of expectations. It was one of the Danish pharma giant's worst days on ...
(CNN) — Since Ozempic blasted onto the stage in 2017 with its approval for type 2 diabetes, drugmakers Novo Nordisk and Eli Lilly have been battling to leapfrog each other with newer and more ...
O Botafogo tem um novo presidente. Na primeira eleição desde que o Alvinegro virou SAF, os sócios do clube elegeram o empresário João Paulo Magalhães para presidir o clube para o próximo ...
Novo Nordisk is exploring a new class of small molecule drugs that act as matchmakers between two proteins in partnership with a biotech startup called … ...
This story was updated to add new information. The parent company of Danish drug maker Novo Nordisk said it completed its $16.5 billion purchase of Catalent, including the Bloomington operations ...
As a private company with Novo Holdings’ partnership and support, we are well-positioned to deliver unparalleled outcomes for our customers and the patients they serve, and ultimately create ...
Novo and Photys plan to work together on multiple PHICS molecules for their chosen cardiometabolic target. Photys is on deck to tackle preclinical efforts, while Novo is slated to take the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback